Philip A. Sharp, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 21,200 shares at $37.57 ($804K) on 2017-01-18, disclosed to the SEC on 2017-01-20.
Open-market sale of $804k ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.57 | 8,800 | $331K | 41.1% |
| 2 | $38.20 | 6,200 | $237K | 29.4% |
| 3 | $38.20 | 6,200 | $237K | 29.4% |
| Total | $37.94 avg | 21,200 | $804K | 100% |
| Filing → |
| ALNY | SELL | 2018-03-13 | $1.9M | — | Filing → |
| ALNY | SELL | 2017-02-03 | $2.0M | — | Filing → |
| ALNY | SELL | 2017-01-27 | $569K | — | Filing → |